Celldex Therapeutics Inc
(15117B103)
Funds Reporting Holdings of Celldex Therapeutics Inc according to 13F filings
Firm Name | Shares Held / Principal Amount | Market Value | Option | Report Period | Effectiveness Date |
---|---|---|---|---|---|
Columbia Wanger Asset Management LLC | 10,772,111 | $30,593k | Dec 31, 2017 | Feb 13, 2018 | |
Managed Account Advisors LLC | 5,365 | $135k | Jun 30, 2015 | Aug 14, 2015 |